These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9700469)

  • 1. High plasma free fatty acids decrease splanchnic glucose uptake in patients with non-insulin-dependent diabetes mellitus.
    Tomita T; Yamasaki Y; Kubota M; Tohdo R; Katsura M; Ikeda M; Nakahara I; Shiba Y; Matsuhisa M; Hori M
    Endocr J; 1998 Apr; 45(2):165-73. PubMed ID: 9700469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.
    Bajaj M; Pratipanawatr T; Berria R; Pratipanawatr W; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
    Diabetes; 2002 Oct; 51(10):3043-8. PubMed ID: 12351445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans.
    Bajaj M; Berria R; Pratipanawatr T; Kashyap S; Pratipanawatr W; Belfort R; Cusi K; Mandarino L; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E346-52. PubMed ID: 12110541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
    Bajaj M; Suraamornkul S; Pratipanawatr T; Hardies LJ; Pratipanawatr W; Glass L; Cersosimo E; Miyazaki Y; DeFronzo RA
    Diabetes; 2003 Jun; 52(6):1364-70. PubMed ID: 12765945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non-insulin-dependent diabetes mellitus. AD-4833 Clamp-OGL Study Group.
    Kawamori R; Matsuhisa M; Kinoshita J; Mochizuki K; Niwa M; Arisaka T; Ikeda M; Kubota M; Wada M; Kanda T; Ikebuchi M; Tohdo R; Yamasaki Y
    Diabetes Res Clin Pract; 1998 Jul; 41(1):35-43. PubMed ID: 9768370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.
    Ludvik B; Nolan JJ; Roberts A; Baloga J; Joyce M; Bell JM; Olefsky JM
    J Clin Invest; 1997 Nov; 100(9):2354-61. PubMed ID: 9410915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
    Boden G; Chen X; Iqbal N
    Diabetes; 1998 Oct; 47(10):1609-12. PubMed ID: 9753299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.
    Kashyap S; Belfort R; Gastaldelli A; Pratipanawatr T; Berria R; Pratipanawatr W; Bajaj M; Mandarino L; DeFronzo R; Cusi K
    Diabetes; 2003 Oct; 52(10):2461-74. PubMed ID: 14514628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents.
    Burns SF; Kelsey SF; Arslanian SA
    Diabetes Care; 2009 Feb; 32(2):355-60. PubMed ID: 19017772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.